| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 10.623.299 $ | 99,57 | 168.424 | |||||||
| AbbVie Inc. | AbbVie Inc. COM | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 796.231 $ | 7,46 | 3.661 | |
| Amgen Inc. | Amgen Inc. COM | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 563.664 $ | 5,28 | 1.602 | |
| Gilead Sciences Inc. | Gilead Sciences Inc. COM | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 533.787 $ | 5,00 | 3.830 | |
| Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated COM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 431.358 $ | 4,04 | 966 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. COM | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 383.229 $ | 3,59 | 496 | |
| Alnylam Pharmaceuticals Inc. | Alnylam Pharmaceuticals Inc. COM | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 280.578 $ | 2,63 | 848 | |
| Insmed Inc | Insmed Inc COM PAR $.01 | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 264.248 $ | 2,48 | 1.616 | |
| BEONE MEDICINES LTD | BeOne Medicines Ltd. SPONSORED ADS | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 246.188 $ | 2,31 | 829 | |
| NATERA INC | Natera Inc. COM | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 225.589 $ | 2,11 | 1.128 | |
| United Therapeutics Corporation | United Therapeutics Corporation COM | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 222.960 $ | 2,09 | 376 | |
| Biogen Inc | Biogen Inc COM | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 216.329 $ | 2,03 | 1.180 | |
| Royalty Pharma PLC | Royalty Pharma PLC COM USD0.0001 CLASS A | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 213.131 $ | 2,00 | 4.443 | |
| Illumina Inc | Illumina Inc COM | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 187.232 $ | 1,75 | 1.519 | |
| Revolution Medicines Inc | Revolution Medicines Inc COM | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 181.955 $ | 1,71 | 1.871 | |
| Moderna Inc | Moderna Inc COM | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 177.444 $ | 1,66 | 3.493 | |
| AstraZeneca PLC | AstraZeneca PLC ORD USD0.25 | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 172.568 $ | 1,62 | 875 | |
| Argenx SE | Argenx SE SPONSORED ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 172.339 $ | 1,62 | 236 | |
| Incyte Corporation. | Incyte Corporation. COM | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 167.439 $ | 1,57 | 1.779 | |
| Viatris Inc | Viatris Inc COM | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 161.620 $ | 1,51 | 11.963 | |
| Bridgebio Pharma Inc | Bridgebio Pharma Inc COM | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 158.471 $ | 1,49 | 2.134 | |
| Alkermes PLC | Alkermes PLC COM USD0.01 | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 158.059 $ | 1,48 | 4.470 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC COM USD0.0001 | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 157.479 $ | 1,48 | 833 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc COM | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 152.555 $ | 1,43 | 1.158 | |
| Guardant Health Inc | Guardant Health Inc COM | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 151.764 $ | 1,42 | 1.643 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd SHS | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 150.965 $ | 1,41 | 5.450 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. COM | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 148.903 $ | 1,40 | 1.983 | |
| Exelixis, Inc. | Exelixis, Inc. COM | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 138.835 $ | 1,30 | 3.237 | |
| Medpace Holdings Inc. | Medpace Holdings Inc. COM | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 135.414 $ | 1,27 | 282 | |
| Biomarin Pharmaceutical Inc. | Biomarin Pharmaceutical Inc. COM | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 133.938 $ | 1,26 | 2.371 | |
| Apellis Pharmaceuticals Inc | Apellis Pharmaceuticals Inc COM | EC | 03753U106 | Long | Börsenkurs (Stufe 1) | 131.834 $ | 1,24 | 3.277 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc COM | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 131.795 $ | 1,24 | 2.102 | |
| Cytokinetics Inc | Cytokinetics Inc COM NEW | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 126.613 $ | 1,19 | 1.921 | |
| Vaxcyte Inc | Vaxcyte Inc COM | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 122.205 $ | 1,15 | 2.103 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG COM CHF0.03 | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 121.541 $ | 1,14 | 2.555 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics Inc COM | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 117.045 $ | 1,10 | 1.811 | |
| BioNTech SE | BioNTech SE SPONSORED ADS | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 114.477 $ | 1,07 | 1.288 | |
| Axsome Therapeutics Inc. | Axsome Therapeutics Inc. COM | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 110.032 $ | 1,03 | 651 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S SPONSORED ADR | EC | 04351P101 | Long | Börsenkurs (Stufe 1) | 108.875 $ | 1,02 | 476 | |
| COGENT BIOSCIENCES INC | Cogent Biosciences Inc. COM | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 106.617 $ | 1,00 | 2.770 | |
| Arcellx Inc | Arcellx Inc COMMON STOCK | EC | 03940C100 | Long | Börsenkurs (Stufe 1) | 106.553 $ | 1,00 | 928 | |
| TG Therapeutics Inc | TG Therapeutics Inc COM | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 103.879 $ | 0,97 | 3.127 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. COM | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 102.808 $ | 0,96 | 1.509 | |
| Scholar Rock Holding Corp. | Scholar Rock Holding Corp. COM | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 101.417 $ | 0,95 | 2.063 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc COM | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 97.365 $ | 0,91 | 186 | |
| Mirum Pharmaceuticals Inc. | Mirum Pharmaceuticals Inc. COM | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 96.352 $ | 0,90 | 1.043 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc COM | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 94.122 $ | 0,88 | 893 | |
| Amicus Therapeutics Inc. | Amicus Therapeutics Inc. COM | EC | 03152W109 | Long | Börsenkurs (Stufe 1) | 87.931 $ | 0,82 | 6.081 | |
| Rhythm Pharmaceuticals Inc | Rhythm Pharmaceuticals Inc COM | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 84.274 $ | 0,79 | 969 | |
| APOGEE THERAPEUTICS INC | Apogee Therapeutics Inc. COM | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 80.972 $ | 0,76 | 962 | |
| Kymera Therapeutics Inc | Kymera Therapeutics Inc COM | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 77.376 $ | 0,73 | 929 | |
| Twist Bioscience Corporation | Twist Bioscience Corporation COM | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 75.984 $ | 0,71 | 1.599 | |
| Viking Therapeutics Inc. | Viking Therapeutics Inc. COM | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 75.948 $ | 0,71 | 2.334 | |
| SUMMIT THERAPEUTICS INC | Summit Therapeutics Inc. COM | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 74.380 $ | 0,70 | 3.923 | |
| Nuvalent Inc | Nuvalent Inc COM | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 73.969 $ | 0,69 | 722 | |
| Acadia Pharmaceuticals Inc | Acadia Pharmaceuticals Inc COM | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 72.167 $ | 0,68 | 3.242 | |
| Travere Therapeutics Inc | Travere Therapeutics Inc COM | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 71.661 $ | 0,67 | 2.412 | |
| Sarepta Therapeutics Inc | Sarepta Therapeutics Inc COM | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 69.784 $ | 0,65 | 3.207 | |
| Celcuity Inc. | Celcuity Inc. COM | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 69.740 $ | 0,65 | 611 | |
| ARCUTIS BIOTHERAPEUTICS INC | Arcutis Biotherapeutics Inc. COM | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 69.337 $ | 0,65 | 2.943 | |
| Veracyte Inc | Veracyte Inc COM | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 68.511 $ | 0,64 | 2.127 | |
| LIQUIDIA CORP | Liquidia Corporation COM NEW | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 66.611 $ | 0,62 | 1.765 | |
| BEAM THERAPEUTICS INC | Beam Therapeutics Inc. COM | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 60.600 $ | 0,57 | 2.543 | |
| Ultragenyx Pharmaceuticals Inc | Ultragenyx Pharmaceuticals Inc COM | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 56.858 $ | 0,53 | 2.714 | |
| Praxis Precision Medicines Inc | Praxis Precision Medicines Inc COM NEW | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 53.806 $ | 0,50 | 167 | |
| GRAIL Inc | GRAIL Inc COM | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 52.869 $ | 0,50 | 1.023 | |
| Soleno Therapeutics Inc | Soleno Therapeutics Inc COM | EC | 834203309 | Long | Börsenkurs (Stufe 1) | 52.463 $ | 0,49 | 1.567 | |
| Recursion Pharmaceuticals Inc | Recursion Pharmaceuticals Inc CL A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 51.131 $ | 0,48 | 16.655 | |
| Krystal Biotech Inc | Krystal Biotech Inc COM | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 50.889 $ | 0,48 | 197 | |
| Intellia Therapeutics Inc | Intellia Therapeutics Inc COM | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 50.549 $ | 0,47 | 3.943 | |
| LEGEND BIOTECH CORP | Legend Biotech Corporation SPONSORED ADS | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 50.543 $ | 0,47 | 2.794 | |
| Adma Biologics Inc | Adma Biologics Inc COM | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 47.140 $ | 0,44 | 5.232 | |
| Akero Therapeutics Inc | Akero Therapeutics Inc | EC | 009CVR044 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 1.848 | |
| SANOFI SA - CVR | SANOFI SA - CVR | EC | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 940 | ||
| 10.623.299 $ | 99,57 | 168.424 |